Ignite Creation Date:
2024-10-26 @ 3:42 PM
Last Modification Date:
2024-10-26 @ 3:42 PM
Study NCT ID:
NCT06632067
Status:
COMPLETED
Last Update Posted:
None
First Post:
2024-10-06
Brief Title:
Sugammadex and Time to Extubation in Ophthalmic Surgery
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Comparison of Sugammadex and Neostigmine for Time to Extubation in Adult Patients Undergoing Routine Ophthalmic Surgery Under General Anesthesia
Status:
COMPLETED
Status Verified Date:
2024-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study is to invastigate if patients treated with sugammadex compared to neostigmineatropine would be extubate faster upon emergence of anesthesia
Detailed Description:
This is a retrospective case-control study including patients aged 18 years or older who underwent ophthalmic surgeries under general anesthesia with tracheal intubation between 2020 and 2022 Patients who received rocuronium as the sole neuromuscular blocking agent and were maintained with sevoflurane or desflurane and intravenous fentanyl were included Based on the choice of reversal agent for neuromuscular blockade patients were divided into two groups the sugammadex group or the neostigmine group Patients who underwent emergency surgery or combined surgeries with other specialties were excluded Patient characteristics including age gender ASA classification weight and height were collected Anesthesia-related medications were recorded The time points of anesthesia induction start and end of surgery reversal agent administration and tracheal extubation were documented
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None